Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Antleron develops enabling technologies—such as the Cell by Design® platform—for personalized cell-based therapies, tissue engineering, organoid production, advanced vaccine manufacturing processes, and point-of-care diagnostic devices. The company specializes in digitalized bioprocess optimization using AI/machine learning to accelerate process development. It collaborates with academic groups and industry partners on projects like heart-on-a-chip models for cardiovascular aging research. No direct clinical results are reported since it acts primarily as an R&D partner/platform provider rather than a drug sponsor.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Antleron.